Stay updated on Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page.

Latest updates to the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRevision metadata updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3 on the page. The old revision tag v3.4.2 was removed and the new v3.4.3 tag added to reflect an update.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2. No study data or user-facing content is affected.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page now displays Revision: v3.4.1 and no longer displays Revision: v3.4.0.SummaryDifference0.0%

- Check67 days agoChange DetectedAdded a glossary display option and updated metadata to Revision: v3.4.0, including Last Update Submitted that Met QC Criteria and No FEAR Act Data. Removed the previous QC-related labels Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.1%

- Check82 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page.